Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with Chemotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Giuseppe Luigi,Banna ^[1] ; Ornella,Cantale ^[2] ; Alex,Friedlaender ^[3] ; Harliana,Yusof ^[1] ; Shyamika,Acharige ^[1] ; Alfredo,Addeo ^[3]

作者单位： Department of Oncology, Queen Alexandra University Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom. ^[1] Department of Experimental Oncology, Mediterranean Institute of Oncology (IOM), Catania, Italy. ^[2] Oncology Department, Geneva University Hospital, Geneva, Switzerland. ^[3]

关键词 SARS-CoV-2 immunotherapy lung cancer mortality neutrophil-to-lymphocyte ratio (NLR)

主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);免疫疗法(Immunotherapy);肺肿瘤(Lung Neoplasms);RNA, 病毒(RNA, Viral);回顾性研究(Retrospective Studies)

DOI 10.1080/07357907.2021.1970761

PMID 34409906

发布时间 2022-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交